Sreeram Ramagopalan

Principal, LCP (London, UK)

Sreeram (Ram) Ramagopalan leads Access Evidence at the consultancy LCP. He previously led Real-World Evidence teams at Roche, Bristol Myers Squibb and Evidera, focused on leveraging real-world evidence for Health Technology Assessment (HTA) to obtain and maintain reimbursement of medicines. Ram has significant experience in strategically planning and utilizing routinely collected data for health economics and outcomes research and market access purposes, and his work on external control arms has been cited as best practice by UK’s NICE.

Ram holds a PhD in Epidemiology from the University of Oxford, an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine and an MSc in Health Economics from the London School of Economics and Political Science. He is an international expert in real-world evidence with over 300 journal publications. He is an IFAPP Global Fellow in Medicines Development and a Visiting Senior Lecturer at the Centre for Pharmaceutical Medicine Research, King’s College London.